Clinical Observation Of Enema With Mengshi She Nlian Decoction In Treating Atrial Fibrillation Caused By Phlegm And Fire

Objective:By observing the clinical efficacy of Mengshishenlian decoction enema in treating patients with phlegm and fire disturbed heart type atrial fibrillation,the safety and efficacy of Mengshishenlian decoction enema in treating phlegm and fire disturbing heart type atrial fibrillation were verified,with a view to applying it to a large area Clinically,it provides a characteristic,effective,convenient and safe prescription and administration route for traditional Chinese medicine treatment of atrial fibrillationMethod:During the period from September 2018 to August 2019,80 patients with atrial fibrillation in the Second Cardiology Ward of Heilongjiang Chinese Medicine Hospital(Nangang Branch)who met the inclusion criteria were randomly divided into a control group and a treatment group according to the medical record number,each group had 40 example The control group received basic Western medicine treatment(including improving blood supply,nourishing myocardium,anti coagulation,and controlling ventricular rate).The treatment group was treated with enema treatment of Mengshi Shenlian Decoction on the basis of western medicine such as improving blood supply,nutrient myocardium,anti coagulation,and controlling ventricular rate.,Single syndrome score,24-hour ambulatory electrocardiogram atrial fibrillation,changes in general safety indicators,data analysis through statistical softwareResult:1.Clinical symptoms of traditional Chinese medicine:After treatment,the clinical symptoms of both groups have been alleviated.The total effective rate of the group of Mengshi Shenlian Decoction is 82.5%,and the total effective rate of the basic treatment group of western medicine is 67.5%.Compared with the two groups,P<0.05,indicating The symptom improvement of the Mengshishenlian decoction group was significantly better than that of the western medicine basic treatment group2.Comparison of individual syndromes of traditional Chinese medicine:Compared with before treatment,the group of Mengshi Shenlian Decoction had P<0.05 in the aspects of palpitations,chest pain,chest tightness,shortness of breath,fatigue,irritability,insomnia,limb distress and anxiety.It has statistical significance,indicating that the Mengshi Shenlian Decoction group has a considerable effect on various TCM syndromes.Compared with the western medicine basic treatment group,P<0.05 in the palpitations,chest tightness,chest pain,fatigue,and irritability,there is a significant difference;in terms of improving shortness of breath,insomnia,limb distress,and narcosis,P>0.05,No statistical difference Comparison between the treatment group of the Mengshi Shenlian Decoction group and the western medicine basic treatment group,the score comparison of chest pain,shortness of breath,fatigue,insomnia,and numbness,P>0.05,incomparable;The symptoms of chest tightness,irritability,and heavy limbs were improved,P<0.05,indicating that the effect of Mengshi Shenlian Decoction group was better than that of the control group3.Dynamic electrocardiogram:after treatment,the total effective rate of the treatment group and the conventional Western medicine group were 87.5%and 77.5%,respectively By comparison,P>0.05,indicating that the conventional Western medicine group and the Yaoshishenlian decoction group after treatment were at 24 hours,There is no obvious difference in the effect of the 24 hour dynamic electrocardiogram.between the conventional Western medicine group and the Mengshishenlian decoction group4.General safety indicators:none of the patients in the western medicine basic treatment group and the Mengshishenlian decoction group had adverse reactions during the test period,and there was no clinically significant change before and after treatment in the laboratoryConclusion:Mengshishenlian decoction has a significant effect on phlegm-fire disturbed heart type atrial fibrillation,and can significantly improve the clinical symptoms of patients with palpitations,chest tightness,shortness of breath,and fatigue,and the safety of clinical use is better.